JPH11222421A - Ultraviolet light shielding agent and its production, and cosmetic - Google Patents
Ultraviolet light shielding agent and its production, and cosmeticInfo
- Publication number
- JPH11222421A JPH11222421A JP3395898A JP3395898A JPH11222421A JP H11222421 A JPH11222421 A JP H11222421A JP 3395898 A JP3395898 A JP 3395898A JP 3395898 A JP3395898 A JP 3395898A JP H11222421 A JPH11222421 A JP H11222421A
- Authority
- JP
- Japan
- Prior art keywords
- ultraviolet
- inorganic powder
- protective agent
- functional group
- silane coupling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 239000000843 powder Substances 0.000 claims abstract description 41
- 125000000524 functional group Chemical group 0.000 claims abstract description 30
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 28
- 239000000741 silica gel Substances 0.000 claims abstract description 28
- 239000006087 Silane Coupling Agent Substances 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003223 protective agent Substances 0.000 claims description 29
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- 230000006750 UV protection Effects 0.000 claims 1
- 239000011814 protection agent Substances 0.000 claims 1
- MQWFLKHKWJMCEN-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN MQWFLKHKWJMCEN-UHFFFAOYSA-N 0.000 abstract description 2
- OUVTVAYAMIIJCQ-UHFFFAOYSA-N 3-(4-methoxyphenyl)prop-2-enoic acid;hydrochloride Chemical compound Cl.COC1=CC=C(C=CC(O)=O)C=C1 OUVTVAYAMIIJCQ-UHFFFAOYSA-N 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- -1 -Aminobenzoic acid Chemical compound 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- 239000000516 sunscreening agent Substances 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 8
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 7
- 230000000475 sunscreen effect Effects 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 150000004756 silanes Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- DNACJYZYGAJDBK-UHFFFAOYSA-N 16-methylheptadecanoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O DNACJYZYGAJDBK-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229910002039 SYLYSIA SY350 Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000012801 ultraviolet ray absorbent Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- CGOJOQBYEAVATL-QPJJXVBHSA-N (e)-3-(4-methoxyphenyl)prop-2-enoyl chloride Chemical compound COC1=CC=C(\C=C\C(Cl)=O)C=C1 CGOJOQBYEAVATL-QPJJXVBHSA-N 0.000 description 1
- CQNPVMCASGWEHM-VMPITWQZSA-N (e)-3-[4-(dimethylamino)phenyl]prop-2-enoic acid Chemical compound CN(C)C1=CC=C(\C=C\C(O)=O)C=C1 CQNPVMCASGWEHM-VMPITWQZSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- RRZWKUGIZRDCPB-UHFFFAOYSA-N 2,3-dihydroxypropyl hexanoate Chemical compound CCCCCC(=O)OCC(O)CO RRZWKUGIZRDCPB-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 1
- ONLPKGMCOFNAJA-UHFFFAOYSA-N 3-methoxysilylpropane-1-thiol Chemical compound CO[SiH2]CCCS ONLPKGMCOFNAJA-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229910008051 Si-OH Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910006358 Si—OH Inorganic materials 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 150000005417 aminobenzoic acid derivatives Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- NFCHYERDRQUCGJ-UHFFFAOYSA-N dimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[SiH](OC)CCCOCC1CO1 NFCHYERDRQUCGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- MASNVFNHVJIXLL-UHFFFAOYSA-N ethenyl(ethoxy)silicon Chemical compound CCO[Si]C=C MASNVFNHVJIXLL-UHFFFAOYSA-N 0.000 description 1
- IBKNSIPMTGYUNZ-UHFFFAOYSA-N ethenyl(methoxy)silane Chemical compound CO[SiH2]C=C IBKNSIPMTGYUNZ-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical class OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 238000000411 transmission spectrum Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- GQIUQDDJKHLHTB-UHFFFAOYSA-N trichloro(ethenyl)silane Chemical compound Cl[Si](Cl)(Cl)C=C GQIUQDDJKHLHTB-UHFFFAOYSA-N 0.000 description 1
- IHYCWJYGNRZAOB-UHFFFAOYSA-N trichloro(hex-5-enyl)silane Chemical compound Cl[Si](Cl)(Cl)CCCCC=C IHYCWJYGNRZAOB-UHFFFAOYSA-N 0.000 description 1
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000005050 vinyl trichlorosilane Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、紫外線防御剤及び
紫外線防御剤の製造方法並びに化粧料に関する。具体的
に言うと、サンスクリーン剤などの化粧料に好適に用い
られる新規な紫外線防御剤及び当該紫外線防御剤の製造
方法並びに当該紫外線防御剤を含有した化粧料に関す
る。TECHNICAL FIELD The present invention relates to an ultraviolet protective agent, a method for producing the ultraviolet protective agent, and a cosmetic. Specifically, the present invention relates to a novel ultraviolet protective agent suitably used for cosmetics such as sunscreen agents, a method for producing the ultraviolet protective agent, and a cosmetic containing the ultraviolet protective agent.
【0002】[0002]
【従来の技術】紫外線の照射により、人の皮膚は種々の
影響を受けることが知られている。通常、人が被る紫外
線の大部分は、太陽光線に由来するものである。この太
陽光線に含まれる紫外線(UV)は、その波長により区
分され、一般に長波長紫外線(400〜320nm)は
UV−A、中波長紫外線(320〜280nm)はUV
−B、短波長紫外線(280nm以下)はUV−Cと呼
ばれている。この中で、UV−Cは、その殆どが大気中
のオゾンによって吸収され、地表に届くことがない。ま
た、UV−Bは、人の皮膚に対して急性の炎症(紅斑、
erythema)や火傷(sunbern)を引き起こし、前記UV
−Aは皮膚への透過性も高く真皮中の弾力繊維、コラー
ゲン、ヒアルロン酸に変化をもたらし、これらの変化が
皮膚の老化の促進につながっていると考えられている。
また、皮膚は紫外線を受けることにより、メラニンの産
出を促進し、過度の紫外線によりシミの沈着を促進す
る。従って、皮膚の老化促進を予防し、しみ、そばかす
の発生及び悪化を防止するために紫外線から皮膚を保護
することが重要となる。ここで、紫外線から皮膚を守る
方法としては、紫外線防御剤の塗布や皮膚への紫外線照
射で発生する活性酸素の除去などがある。現在のとこ
ろ、両者のうち紫外線防御剤の皮膚への塗布が、簡単で
かつ最も有効であると考えられている。2. Description of the Related Art It is known that human skin is variously affected by irradiation of ultraviolet rays. Normally, most of the ultraviolet rays that humans receive are derived from sunlight. The ultraviolet rays (UV) contained in the sunlight rays are classified according to their wavelengths.
-B, short wavelength ultraviolet light (280 nm or less) is called UV-C. Among them, most of UV-C is absorbed by ozone in the atmosphere and does not reach the surface of the earth. UV-B also causes acute inflammation (erythema,
erythema) and burns (sunbern) causing the UV
-A has high permeability to the skin and causes changes in elastic fibers, collagen and hyaluronic acid in the dermis, and it is thought that these changes lead to promotion of skin aging.
In addition, the skin receives ultraviolet rays to promote the production of melanin, and excessive ultraviolet rays promotes the deposition of spots. Therefore, it is important to protect the skin from UV radiation in order to prevent accelerated aging of the skin and to prevent the occurrence and deterioration of spots and freckles. Here, as a method of protecting the skin from ultraviolet rays, there are a method of applying an ultraviolet protective agent and a method of removing active oxygen generated by irradiating the skin with ultraviolet rays. At present, application of the UV protective agent to the skin is considered to be the simplest and most effective.
【0003】紫外線防御剤には主として、照射された紫
外線を吸収する紫外線吸収剤と照射された紫外線を反射
する紫外線反射剤が挙げられる。公知の紫外線吸収剤と
して、例えば桂皮酸誘導体、アミノ安息香酸誘導体、サ
リチル酸誘導体、ベンゾフェノン誘導体、ウロカニン酸
誘導体等が知られているが、これらは低分子化合物であ
るために皮膚に塗布した場合、経皮吸収される可能性が
あり、安全性が高いとは言えない。また、紫外線反射剤
として、紫外線の散乱効果を持つ酸化チタンや酸化亜鉛
等の無機粉体が用いられており、これらは経皮吸収され
る可能性が小さく、安全性の観点からは好ましいもので
ある。[0003] The ultraviolet ray protective agent mainly includes an ultraviolet ray absorbent for absorbing the irradiated ultraviolet ray and an ultraviolet ray reflector for reflecting the irradiated ultraviolet ray. As known UV absorbers, for example, cinnamic acid derivatives, aminobenzoic acid derivatives, salicylic acid derivatives, benzophenone derivatives, urocanic acid derivatives and the like are known. It may be absorbed by the skin and is not very safe. In addition, inorganic powders such as titanium oxide and zinc oxide, which have a scattering effect of ultraviolet rays, are used as the ultraviolet reflector, and these are less likely to be percutaneously absorbed, and are preferable from the viewpoint of safety. is there.
【0004】しかしながら、このような酸化チタンや酸
化亜鉛等の無機粉体にあっては、透明性(透明度)が小
さいため、その使用はかなり制限されるものであった。However, the use of such inorganic powders such as titanium oxide and zinc oxide has been considerably limited because of their low transparency (transparency).
【0005】また、近年、これらの無機粉体を微粒子化
し、表面処理をすることにより、紫外線に対する効果を
維持しながら透明度を上げる工夫が数々なされている
が、まだ充分なものではない。In recent years, various methods have been devised to increase the transparency while maintaining the effect on ultraviolet rays by making these inorganic powders finer and surface-treating them, but they have not been sufficient.
【0006】本発明は叙上の従来例の欠点に鑑みてなさ
れたものであり、安全性に優れ、かつ透明性の高い紫外
線防御剤を提供することにある。The present invention has been made in view of the above-mentioned drawbacks of the conventional examples, and has as its object to provide an ultraviolet protective agent which is excellent in safety and has high transparency.
【0007】本願発明者らは、上記問題点を解決するた
め鋭意検討した結果、透明度の高いシリカゲルなどの無
機粉体に紫外線吸収能を有する官能基を導入することに
より、本発明を完成するに至った。The inventors of the present application have conducted intensive studies to solve the above-mentioned problems, and as a result, they have completed the present invention by introducing a functional group having an ultraviolet absorbing ability into inorganic powder such as silica gel having high transparency. Reached.
【0008】[0008]
【課題を解決するための手段】本発明に係る紫外線防御
剤は、無機粉体の表面に、紫外線吸収性官能基を有する
ことを特徴としている。より具体的には、無機粉体の表
面に、シランカップリング剤を介して紫外線吸収能を有
する紫外線吸収性官能基が結合されたことを特徴として
いる。The ultraviolet protective agent according to the present invention is characterized in that the surface of the inorganic powder has an ultraviolet absorbing functional group. More specifically, it is characterized in that an ultraviolet absorbing functional group having an ultraviolet absorbing ability is bonded to the surface of the inorganic powder via a silane coupling agent.
【0009】ここで紫外線吸収性官能基とは、紫外線領
域に吸収スペクトルを有する一群の機能原子団を意味
し、広く紫外線吸収剤として用いられる紫外線吸収性化
合物のアルキル残基やカルボン酸残基、アルコール残
基、アミノ残基、アシル基などを総称したものを意味す
る。また、残基とは、化合物中のカルボキシル基や水酸
基、アミノ基などから水素原子を除いたものを意味す
る。すなわち、本発明において、紫外線吸収性官能基と
は、広く紫外線吸収性化合物中のカルボキシル基や水酸
基、アミノ基などから水素原子を除いた原子団や紫外線
吸収性化合物中のアシル基等を意味するものとする。Here, the term "ultraviolet absorbing functional group" means a group of functional atomic groups having an absorption spectrum in the ultraviolet region, such as an alkyl residue or a carboxylic acid residue of an ultraviolet absorbing compound widely used as an ultraviolet absorbent. It means a general term for alcohol residues, amino residues, acyl groups and the like. The residue means a compound obtained by removing a hydrogen atom from a carboxyl group, a hydroxyl group, an amino group, or the like in a compound. That is, in the present invention, the ultraviolet-absorbing functional group broadly means a carboxyl group or a hydroxyl group in the ultraviolet-absorbing compound, an atomic group obtained by removing a hydrogen atom from an amino group, an acyl group in the ultraviolet-absorbing compound, or the like. Shall be.
【0010】また、本発明において用いられる紫外線吸
収性化合物としては、例えば、UV−B領域に吸収スペ
クトルを有する化合物として、p−メトキシ桂皮酸、p
−アミノ安息香酸、p−ジメチルアミノ安息香酸、サリ
チル酸などが挙げられる。また、UV−A領域に吸収ス
ペクトルを有するものとして、p−ジメチルアミノ桂皮
酸などが挙げられる。さらに、これら以外にも、桂皮酸
やゲンチジン酸、没食子酸などのカルボン酸類、桂皮ア
ルコール等のアルコール類など、従来から公知である各
種の紫外線吸収性化合物を挙げることができ、紫外線吸
収性官能基としては、これら化合物のカルボン酸残基や
アルコール残基などを用いることができる。The ultraviolet absorbing compounds used in the present invention include, for example, p-methoxycinnamic acid, p-methoxycinnamic acid,
-Aminobenzoic acid, p-dimethylaminobenzoic acid, salicylic acid and the like. Examples of those having an absorption spectrum in the UV-A region include p-dimethylaminocinnamic acid. Furthermore, in addition to these, various conventionally known ultraviolet absorbing compounds, such as carboxylic acids such as cinnamic acid and gentisic acid, and gallic acid, and alcohols such as cinnamic alcohol, can be mentioned. For example, carboxylic acid residues or alcohol residues of these compounds can be used.
【0011】これらの紫外線吸収性官能基は、以下に述
べるようにシランカップリング剤を介して無機粉体の表
面に結合されるものであり、紫外線吸収性化合物とし
て、シランカップリング剤と反応性のある官能基を有す
るものであれば、特に限定されるものではない。また、
結合しようとする紫外線吸収性化合物自体に反応性がな
い場合や小さい場合には、後述するように、例えばカル
ボン酸ハロゲン化合物やハロゲン化アルキルなどのよう
に反応性を高めたり、あるいは、紫外線吸収性化合物に
カルボキシル基やアミノ基などの反応性官能基を導入し
てもよい。These UV-absorbing functional groups are bonded to the surface of the inorganic powder through a silane coupling agent as described below. It is not particularly limited as long as it has a functional group having a certain property. Also,
If the UV absorbing compound to be bonded is not reactive or is small, it may increase the reactivity, for example, a carboxylic acid halogen compound or an alkyl halide, as described below, or A reactive functional group such as a carboxyl group or an amino group may be introduced into the compound.
【0012】無機粉体としては、通常の化粧料に使用さ
れているものに適用することができるが、シランカップ
リング剤と反応可能な無機粉体、具体的に言うと、以下
に述べるようなシランカップリング剤と反応可能な官能
基、特に水酸基を、表面に有する無機粉体が好ましい。
例えば、シリカゲル、カオリン、タルク、セリサイト、
リン酸三カルシウムなどを挙げることができる。The inorganic powder can be applied to those used in ordinary cosmetics. Inorganic powder capable of reacting with a silane coupling agent, specifically, as described below. An inorganic powder having on its surface a functional group capable of reacting with the silane coupling agent, particularly a hydroxyl group, is preferred.
For example, silica gel, kaolin, talc, sericite,
Tricalcium phosphate and the like can be mentioned.
【0013】また、これらの無機粉体の中で、サンスク
リーン化粧料として幅広く適用できるように、透明性の
高い無機粉体が好適に用いられる。中でも、シランカッ
プリング剤を導入しやすく、しかも透明性が高くて安価
に入手できる点で、シリカゲルが特に好ましく用いられ
る。さらに、化粧料の使用感や紫外線防御能などの観点
から、粒子径は小さい程好ましく、10μm以下のも
の、より具体的には0.01〜10μmのものが好適
で、例えば粉末シリカゲルや微粉末シリカゲルを用いる
のが望ましい。Among these inorganic powders, inorganic powders having high transparency are preferably used so as to be widely applicable as sunscreen cosmetics. Among them, silica gel is particularly preferably used because it is easy to introduce a silane coupling agent, is highly transparent, and can be obtained at low cost. Furthermore, from the viewpoints of the feeling of use of the cosmetic and the ability to protect against ultraviolet rays, the smaller the particle size, the more preferable the particle size is 10 μm or less, more specifically, 0.01 to 10 μm. Preferably, silica gel is used.
【0014】本発明において、シランカップリング剤と
はシラン誘導体であって、上記の紫外線吸収性化合物と
反応性を示す反応性官能基を有する化合物を意味し、特
に上記無機粉体表面の水酸基などと反応性が高いもの、
例えば、加水分解などによりSi−OH基を生成するメ
トキシ基やエトキシ基などのアルコキシル基含有シラン
誘導体やSi−Cl基含有シラン誘導体が好ましく用い
られる。また、結合しようとする紫外線吸収性官能基
(若しくは紫外線吸収性化合物)に応じて、適宜選択さ
れる。In the present invention, the silane coupling agent is a silane derivative, which means a compound having a reactive functional group which is reactive with the above-mentioned ultraviolet absorbing compound, especially a hydroxyl group on the surface of the above-mentioned inorganic powder. Is highly reactive with
For example, a silane derivative containing an alkoxyl group such as a methoxy group or an ethoxy group that generates a Si-OH group by hydrolysis or the like, or a silane derivative containing a Si-Cl group is preferably used. Further, it is appropriately selected according to the ultraviolet absorbing functional group (or ultraviolet absorbing compound) to be bonded.
【0015】より具体的に言えば、アルコキシル基含有
シラン誘導体としては、反応性官能基にビニル系官能基
を有するものとして、ビニルメトキシシランやビニルエ
トキシシラン等が、アミノ系官能基を有するものとし
て、アミノプロピルシランやアミノプロピルトリエトキ
シシラン、N−(2−アミノエチル)3−アミノプロピ
ルメチルジメトキシシラン、N−(2−アミノエチル)
3−アミノプロピルトリメトキシシラン等が、エポキシ
系官能基を有するものとして、3−グリシドキシプロピ
ルトリメトキシシランや3−グリシドキシプロピルジメ
トキシシラン、クロル系官能基を有するものとして、3
−クロロプロピルメチルジメトキシシランや3−メタク
リロシプロピルトリメトキシシラン、メルカプト系の官
能基を有するものとして3−メルカプトプロピルメトキ
シシラン等が挙げられる。また、Si−Cl基含有シラ
ン誘導体としては、ビニル系官能基を有するものとし
て、5−ヘキセニルトリクロロシランやビニルトリクロ
ロシランなどが挙げられる。もちろん、無機粉体と結合
可能であれば、これらのシアンカップリング剤に限定さ
れるものではない。More specifically, the alkoxyl group-containing silane derivatives include those having a vinyl functional group as a reactive functional group, and those having an amino functional group such as vinyl methoxy silane and vinyl ethoxy silane. , Aminopropylsilane, aminopropyltriethoxysilane, N- (2-aminoethyl) 3-aminopropylmethyldimethoxysilane, N- (2-aminoethyl)
Examples of 3-aminopropyltrimethoxysilane and the like having an epoxy functional group include 3-glycidoxypropyltrimethoxysilane and 3-glycidoxypropyldimethoxysilane, and those having a chloro functional group.
-Chloropropylmethyldimethoxysilane, 3-methacryloxypropyltrimethoxysilane, and 3-mercaptopropylmethoxysilane having a mercapto-type functional group are exemplified. Examples of the Si-Cl group-containing silane derivative having a vinyl-based functional group include 5-hexenyltrichlorosilane and vinyltrichlorosilane. Of course, the present invention is not limited to these cyan coupling agents as long as they can be combined with the inorganic powder.
【0016】本発明に係る紫外線防御剤は、次に述べる
ような方法で簡単に作製できる。まず、無機粉体に上記
シランカップリング剤を常法により結合する。例えば、
ヘンシェルミキサーやVブレンダーなどの各種ミキサー
中で無機粉体を攪拌しながら、シランカップリング剤を
直接あるいは水系又は非水系の溶媒で希釈した溶液を、
ミキサー中に添加する方法(乾式法)、また、無機粉体
を水系又は非水系の溶媒に分散させてスラリー状態と
し、このものに、シランカップリング剤を直接あるいは
水系又は非水系の溶媒で希釈した溶液を添加する方法
(湿式法)、あるいは、炉中で高温にした無機粉体に、
シランカップリング剤を直接あるいは水系又は非水系の
溶媒で希釈した溶液をスプレーするスプレー法などによ
り、シランカップリング剤を結合させる。The ultraviolet protective agent according to the present invention can be easily prepared by the following method. First, the silane coupling agent is bonded to the inorganic powder by a conventional method. For example,
While stirring the inorganic powder in various mixers such as a Henschel mixer or a V blender, a solution obtained by diluting the silane coupling agent directly or with an aqueous or non-aqueous solvent,
Addition into a mixer (dry method), or dispersion of an inorganic powder in an aqueous or non-aqueous solvent to form a slurry, and diluting the silane coupling agent directly or with an aqueous or non-aqueous solvent Method (wet method), or inorganic powder heated to a high temperature in a furnace,
The silane coupling agent is bound by a spray method of spraying a solution obtained by diluting the silane coupling agent directly or with an aqueous or non-aqueous solvent.
【0017】次に、シランカップリング剤と上記紫外線
吸収性官能基を結合させる。この方法としては、上記紫
外線吸収性官能基の有する反応性官能基、つまり、上記
紫外線吸収性官能基中の水酸基やカルボキシル基と、シ
ランカップリング剤中のビニル基やアミノ基、エポキシ
基、クロル基、メルカプト基、水酸基などを常法により
反応させる。Next, the silane coupling agent is bonded to the ultraviolet absorbing functional group. As this method, a reactive functional group of the ultraviolet absorbing functional group, that is, a hydroxyl group or a carboxyl group in the ultraviolet absorbing functional group, a vinyl group or an amino group, an epoxy group, a chloro group in a silane coupling agent. Groups, mercapto groups, hydroxyl groups and the like are reacted by a conventional method.
【0018】例えば、上記紫外線吸収性官能基を有する
カルボン酸化合物(p−メトキシ桂皮酸、p−アミノ安
息香酸、p−ジメチルアミノ安息香酸、サリチル酸な
ど)と、上記シランカップリング剤中のアミノ基やメル
カプト基、水酸基などと反応させ、酸アミド結合やチオ
エステル結合、エステル結合を形成する。あるいは、上
記紫外線吸収性官能基を有するアルコール化合物(桂皮
アルコールなど)を用いて、上記シランカップリング剤
中のエポキシ基と反応させ、オキシエーテル結合を形成
して、目的とする紫外線防御剤を得ることができる。こ
のとき、上記したように紫外線吸収性化合物の反応性が
弱い場合には、紫外線吸収性化合物を、例えばカルボン
酸ハロゲンやアルコキシドなどの反応性の高い化合物と
した後、シランカップリング剤と反応させてもよい。For example, a carboxylic acid compound having the above-mentioned ultraviolet absorbing functional group (p-methoxycinnamic acid, p-aminobenzoic acid, p-dimethylaminobenzoic acid, salicylic acid, etc.) and an amino group in the silane coupling agent To form an acid amide bond, a thioester bond, or an ester bond. Alternatively, an alcohol compound having an ultraviolet absorbing functional group (such as cinnamon alcohol) is reacted with an epoxy group in the silane coupling agent to form an oxyether bond, thereby obtaining a desired ultraviolet protective agent. be able to. At this time, when the reactivity of the ultraviolet absorbing compound is weak as described above, the ultraviolet absorbing compound is converted to a highly reactive compound such as a carboxylic acid halogen or an alkoxide, and then reacted with a silane coupling agent. You may.
【0019】このようにして得られた紫外線防御剤は、
すぐれた紫外線吸収能を有すると共に、無機粉体が結合
されているため皮膚からの吸収が少なく、数々のサンス
クリーン化粧品に応用することができる。The ultraviolet protective agent thus obtained is
In addition to having excellent ultraviolet absorbing ability, it has little absorption from the skin due to the binding of inorganic powder, and can be applied to various sunscreen cosmetics.
【0020】[0020]
【発明の実施の形態】次に、本発明に係る紫外線防御剤
を実際に作製し、本発明の効果を確認した。尚、本発明
は以下の実施例に限られるものではない。 (実施例)無機粉体として、シリカゲル(「SYLYS
IA350」、富士シリシア化学社製、平均粒径1.8
μm)、シリカゲル(「BW300」、富士シリシア化
学社製、平均粒径60μm)、シリカゲル(「エロジー
ル200」、日本アエロジル社製、平均粒径0.012
μm)、リン酸三ナトリウム(和光純薬社製)、カオリ
ン(「カオリンKF」、堀クレー社製)、セリサイト
(「セリサイトGMS−C」、キンゼイマティック社
製)、タルク(「タルクMS」、日本タルク社製)を用
い、以下のようにして本発明に係る紫外線防御剤を得
た。Next, an ultraviolet protective agent according to the present invention was actually prepared, and the effect of the present invention was confirmed. The present invention is not limited to the following embodiments. (Example) Silica gel ("SYLYS") was used as the inorganic powder.
IA350 ", manufactured by Fuji Silysia Chemical Ltd., average particle size 1.8
μm), silica gel (“BW300”, manufactured by Fuji Silysia Chemical Ltd., average particle size: 60 μm), silica gel (“Ezile 200”, manufactured by Nippon Aerosil Co., Ltd., average particle size: 0.012)
μm), trisodium phosphate (manufactured by Wako Pure Chemical Industries, Ltd.), kaolin (“Kaolin KF”, manufactured by Hori Clay Co., Ltd.), sericite (“Serisite GMS-C”, manufactured by Kinseimatic Co., Ltd.), talc (“Talc MS” ", Manufactured by Nippon Talc Co., Ltd.) to obtain an ultraviolet protective agent according to the present invention as follows.
【0021】上記各無機粉体50gに、ベンゼン800
mlを加え、共沸蒸留を行ない、水分を除いた。その
後、減圧下でベンベンを除去した無機粉体40gに、ベ
ンゼン800ml、アミノプロピルトリエトキシシラン
(商品名「S330」、チッソ製)22.5mlを加
え、24時間還流した。この反応処理物をベンゼン、エ
タノール、水、エタノールの順で洗浄し、表面にシラン
カップリング剤を結合させた無機粉体を得た。To 50 g of each of the above inorganic powders, 800 benzene
Then, azeotropic distillation was performed to remove water. Thereafter, 800 ml of benzene and 22.5 ml of aminopropyltriethoxysilane (trade name “S330”, manufactured by Chisso) were added to 40 g of the inorganic powder from which bemben was removed under reduced pressure, and the mixture was refluxed for 24 hours. The reaction product was washed with benzene, ethanol, water, and ethanol in that order to obtain an inorganic powder having a silane coupling agent bonded to the surface.
【0022】次に、このシランカップリング剤を結合さ
せた無機粉体20gにベンゼンを加え、p−メトキシ桂
皮酸クロライド16g及びトリエチルアミン12mlを
加え、24時間還流した。その後、この反応処理物をベ
ンゼン、エタノールで順次洗浄後、減圧下で乾燥し、実
施例である各種のp−メトキシ桂皮酸−アミノプロピル
トリエトキシシラン−無機粉体化合物を得た。Next, benzene was added to 20 g of the inorganic powder to which the silane coupling agent had been bound, 16 g of p-methoxycinnamic acid chloride and 12 ml of triethylamine were added, and the mixture was refluxed for 24 hours. Thereafter, the reaction product was washed with benzene and ethanol in that order, and dried under reduced pressure to obtain various p-methoxycinnamic acid-aminopropyltriethoxysilane-inorganic powder compounds of Examples.
【0023】〔元素分析〕実施例で得た各種のp−メト
キシ桂皮酸−アミノプロピルトリエトキシシラン−無機
粉体化合物について、元素分析を行なった。その結果を
表1に示す。[Elemental Analysis] Elemental analysis was performed on various p-methoxycinnamic acid-aminopropyltriethoxysilane-inorganic powder compounds obtained in Examples. Table 1 shows the results.
【0024】[0024]
【表1】 [Table 1]
【0025】〔紫外線吸収能及び透明度の測定〕次に、
本発明の効果を確認すべく、紫外線吸収能及び透明度に
ついて測定した。測定には、実施例中シリカゲルとして
「エロジール200」を用いたp−メトキシ桂皮酸−ア
ミノプロピルトリエトキシシラン−シリカゲル化合物を
用いた。また、比較例として、未処理のシリカゲル「エ
ロジール200」並びに未処理の微粒子酸化チタンを用
いた。[Measurement of UV Absorbing Capacity and Transparency]
In order to confirm the effects of the present invention, the ultraviolet absorption capacity and the transparency were measured. For the measurement, a p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound using "Ezile 200" as the silica gel in the examples was used. As comparative examples, untreated silica gel “Ezile 200” and untreated fine particle titanium oxide were used.
【0026】p−メトキシ桂皮酸−アミノプロピルトリ
エトキシシラン−シリカゲル化合物及び未処理のシリカ
ゲル並びに酸化チタンをそれぞれヒマシ油を基剤として
5w/w%濃度(但し、酸化チタンについては1w/w
%)にし、乳鉢にて均一に分散した。これらの試料各2
5mgをそれぞれ石英板上に塗布した後、別な石英板で
挟み込み、直径約2cmの円形の薄膜を作製した。この
ものを分光光度計を用いて、240〜600nmにおけ
る透過率(透過度)を測定した。その結果を、図1に示
した。また、400〜600nmにおける平均透明度
(図1の透過度面積により算出)を表2に示した。The p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound, untreated silica gel and titanium oxide were each used as a base in castor oil at a concentration of 5% w / w (however, 1% w / w for titanium oxide).
%) And uniformly dispersed in a mortar. Each of these samples 2
After applying 5 mg each on a quartz plate, it was sandwiched between different quartz plates to produce a circular thin film having a diameter of about 2 cm. This was measured for transmittance (transmittance) at 240 to 600 nm using a spectrophotometer. The result is shown in FIG. Table 2 shows the average transparency at 400 to 600 nm (calculated from the transmittance area in FIG. 1).
【0027】[0027]
【表2】 [Table 2]
【0028】図1から分かるように、本発明に係る実施
例にあっては、UV−B領域(320nm〜280n
m)における紫外線吸収率が低下しており、p−メトキ
シ桂皮酸による紫外線吸収能が確認された。また、40
0〜600nmにおける平均透明度は95%以上であ
り、透明性も優れたものであった。As can be seen from FIG. 1, in the embodiment according to the present invention, the UV-B region (320 nm to 280 nm) is used.
In m), the ultraviolet absorptivity was reduced, and the ultraviolet absorptivity by p-methoxycinnamic acid was confirmed. Also, 40
The average transparency at 0 to 600 nm was 95% or more, and the transparency was also excellent.
【0029】〔安全性試験〕次に本発明に係る紫外線防
御剤の安全性について、皮膚1次刺激性試験及び皮膚累
積刺激性試験を行なった。[Safety Test] Next, a primary skin irritation test and a cumulative skin irritation test were conducted for the safety of the ultraviolet protective agent according to the present invention.
【0030】4週齢のハートレー系雄性モルモットを1
週間予備飼育を行ない、一般状態の良好なものを試験に
供した。1群を5匹とし、室温22±2℃、湿度60±
10%の飼育条件とした。試験には、実施例中、シリカ
ゲルとして「SYLYSIA350」を用いたp−メト
キシ桂皮酸−アミノプロピルトリエトキシシラン−シリ
カゲル化合物を用い、比較例としてp−メトキシ桂皮酸
及びp−メトキシ桂皮酸オクチルを用いた。One 4-week-old male Hartley guinea pig was
Preliminary breeding was performed for a week, and those with good general conditions were subjected to the test. One group consists of 5 animals, room temperature 22 ± 2 ° C, humidity 60 ±
The breeding conditions were 10%. In the test, a p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound using "SYLYSIA350" as a silica gel in the examples was used, and p-methoxycinnamic acid and octyl p-methoxycinnamate were used as comparative examples. Was.
【0031】p−メトキシ桂皮酸−アミノプロピルトリ
エトキシシラン−シリカゲル化合物、p−メトキシ桂皮
酸、p−メトキシ桂皮酸オクチルをそれぞれ白色ワセリ
ンを基剤として、濃度がp−メトキシ桂皮酸に換算して
0.3Mとなるように調整した。The p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound, p-methoxycinnamic acid, and octyl p-methoxycinnamate were each converted into p-methoxycinnamic acid using white petrolatum as a base. It was adjusted to be 0.3M.
【0032】皮膚1次刺激性試験では、モルモットの側
腹部を剃毛し、各試料0.1gをパッチテスト用絆創膏
を用いて、24時間閉塞貼付して剥離した後、24時間
経過毎に4日間観察を行なった。In the primary skin irritation test, the flank of a guinea pig was shaved and 0.1 g of each sample was closed and peeled off using a patch test bandage for 24 hours. Observations were made for days.
【0033】また、皮膚累積刺激性試験では、モルモッ
トの側腹部を剃毛し、毎日1回各0.1gをパッチテス
ト用絆創膏を用いて24時間閉塞貼付し、4日間連続投
与した。なお、観察は24時間経過毎に行なった。In the skin cumulative irritation test, the guinea pigs were shaved on the flanks and 0.1 g each of the guinea pigs was applied once a day using a patch for patch test for 24 hours, followed by continuous administration for 4 days. The observation was performed every 24 hours.
【0034】評価はDrazeの評価法に従い、次に判
断基準によってそれぞれ評価し、皮膚1次刺激性試験の
結果を表3に、皮膚累積刺激性試験の結果を表4に示し
た。なお、表には1群の平均評価を示した。The evaluation was performed according to the Draze evaluation method, and then evaluated according to criteria. Table 3 shows the results of the primary skin irritation test and Table 4 shows the results of the cumulative skin irritation test. The table shows the average evaluation of one group.
【0035】(紅斑形成) ・紅斑なし 0点 ・散在的に保赤を伴った皮疹 1点 ・ごく軽度の紅斑 2点 ・境界が明確な紅斑 3点 ・中程度から強度の紅斑 4点 ・強度の紅斑 5点(Erythema formation) 0 no erythema 1 rash with scattered redness 1 2 very erythema mildly 3 erythema with clear borders 4 erythema with moderate to strong intensity 4 erythema Erythema 5 points
【0036】(浮腫形成) ・浮腫なし 0点 ・ごく軽度の浮腫 1点 ・軽度の浮腫 2点 ・中等度の浮腫 3点 ・強度の浮腫 4点(Edema formation) ・ No edema 0 points ・ Very mild edema 1 point ・ Mild edema 2 points ・ Moderate edema 3 points ・ Strong edema 4 points
【0037】[0037]
【表3】 [Table 3]
【0038】[0038]
【表4】 [Table 4]
【0039】表3及び表4から分かるように、24時間
貼付の皮膚1次刺激性試験及び4日間連続投与の皮膚累
積刺激性試験のいずれにおいても、紅斑形成や浮腫形成
が見られず、皮膚刺激性のないことが確認された。As can be seen from Tables 3 and 4, neither erythema formation nor edema formation was observed in the skin primary irritation test applied for 24 hours and in the skin cumulative irritation test administered continuously for 4 days. No irritation was observed.
【0040】次に、上記で得られた実施例中、シリカゲ
ルとして「SYLYSIA350」を用いたp−メトキ
シ桂皮酸−アミノプロピルトリエトキシシラン−シリカ
ゲル化合物を用いて、本発明に係る化粧料(サンスクリ
ーン化粧料)を作製した。Next, in the examples obtained above, the cosmetic (sunscreen) according to the present invention was prepared by using p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound using "SYLYSIA350" as silica gel. Cosmetics).
【0041】 (処方例1)サンスクリーンクリーム(W/O型) 〈組成〉 (重量%) p−メトキシ桂皮酸−アミノプロピルトリエトキシシラン −シリカゲル化合物 10.0 pーメトキシ桂皮酸オクチル 2.0 スクワラン 36.0 マイクロクリスタリンワックス 1.0 ジイソステアリン酸グリセリン 3.0 1,3−ブチレングリコール 4.0 グリセリン 5.0 防腐剤・酸化防止剤 適 量 香料 適 量 精製水 残 量(Prescription Example 1) Sunscreen cream (W / O type) <Composition> (% by weight) p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound 10.0 p-octyl octyl methoxycinnamate 2.0 squalane 36.0 Microcrystalline wax 1.0 Glycerin diisostearate 3.0 1,3-butylene glycol 4.0 Glycerin 5.0 Preservative / antioxidant qs Perfume qs Purified water balance
【0042】上記成分の内、p−メトキシ桂皮酸−アミ
ノプロピルトリエトキシシラン−シリカゲル化合物から
ジイソステアリン酸グリセリンまでの5成分並びに防腐
剤・酸化防止剤を混合し、加熱溶解させて油相とした。
これとは別に1,3−ブチレングリコール及びグリセリ
ンを精製水に加熱溶解して得た水相を、前記油相に加え
乳化した。この後、攪拌しながら冷却し、香料を加えク
リーム剤を得た。Of the above components, five components from a p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound to glycerin diisostearate, and a preservative and antioxidant were mixed and dissolved by heating to form an oil phase.
Separately, an aqueous phase obtained by heating and dissolving 1,3-butylene glycol and glycerin in purified water was added to the oil phase and emulsified. Thereafter, the mixture was cooled with stirring, and a flavor was added to obtain a cream.
【0043】 (処方例2)サンスクリーンオイル 〈組成〉 (重量%) p−メトキシ桂皮酸−アミノプロピルトリエトキシシラン −シリカゲル化合物 10.0 スクワラン 60.0 セチルオクタノエート 29.8 酸化防止剤 適 量 香料 適 量(Formulation Example 2) Sunscreen oil <Composition> (% by weight) p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound 10.0 squalane 60.0 cetyl octanoate 29.8 antioxidant Amount Perfume Appropriate amount
【0044】上記成分を混合し、加熱溶解してオイルを
得た。The above components were mixed and dissolved by heating to obtain an oil.
【0045】 (処方例3)サンスクリーン乳液 〈組成〉 (重量%) p−メトキシ桂皮酸−アミノプロピルトリエトキシシラン −シリカゲル化合物 10.0 スクワラン 8.0 ワセリン 2.0 ミツロウ 0.5 ソルビタンセスキオレエート 0.8 ポリオキシエチレンオレイルエーテル(20E.O.) 1.2 カルボキシビニルポリマー 0.2 プロピレングリコール 0.5 水酸化カリウム 0.1 エチルアルコール 7.0 防腐剤・酸化防止剤 適 量 香料 適 量 精製水 残 量(Formulation Example 3) Sunscreen emulsion <Composition> (% by weight) p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound 10.0 squalane 8.0 petrolatum 2.0 beeswax 0.5 sorbitan sesquiole Eat 0.8 Polyoxyethylene oleyl ether (20EO) 1.2 Carboxyvinyl polymer 0.2 Propylene glycol 0.5 Potassium hydroxide 0.1 Ethyl alcohol 7.0 Preservative / antioxidant Appropriate amount Perfume Appropriate Volume Purified water balance
【0046】上記成分の内、p−メトキシ桂皮酸−アミ
ノプロピルトリエトキシシラン−シリカゲル化合物から
ポリオキシエチレンオレイルエーテルまでの6成分並び
に防腐剤・酸化防止剤を混合し、加熱溶解させて油相と
した。これとは別にカルボキシビニルポリマーとプロピ
レングリコール及びアルコールを精製水に加熱溶解して
得た水相を、前記油相に加え乳化した。この後、水酸化
カリウムを加えて増粘し、攪拌しながら冷却して香料を
加え、乳液を得た。Of the above components, six components from p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound to polyoxyethylene oleyl ether and a preservative / antioxidant are mixed, heated and dissolved, and mixed with an oil phase. did. Separately, an aqueous phase obtained by heating and dissolving a carboxyvinyl polymer, propylene glycol and alcohol in purified water was added to the oil phase and emulsified. Thereafter, potassium hydroxide was added to increase the viscosity, and the mixture was cooled with stirring, and a flavor was added to obtain an emulsion.
【0047】 (処方例4)パウダー状サンスクリーン剤 〈組成〉 (重量%) p−メトキシ桂皮酸−アミノプロピルトリエトキシシラン −シリカゲル化合物 15.0 タルク 15.0 マイカ 20.0 セリサイト 40.0 メチルポリシロキサン 5.0 スクワラン 3.0 トリ2−エチルヘキサン酸グリセリル 2.5 防腐剤・酸化防止剤 適 量 色顔料 適 量(Formulation Example 4) Powder-like sunscreen agent <Composition> (% by weight) p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound 15.0 talc 15.0 mica 20.0 sericite 40.0 Methylpolysiloxane 5.0 Squalane 3.0 Glyceryl tri-2-ethylhexanoate 2.5 Preservative / antioxidant Suitable amount Color pigment Suitable amount
【0048】上記成分の内、p−メトキシ桂皮酸−アミ
ノプロピルトリエトキシシラン−シリカゲル化合物から
セリサイトの4成分並びに色顔料を混合した後、攪拌し
ながら、メチルポリシロキサン及びスクワラン並びにト
リ2−エチルヘキサン酸グリセリルと防腐剤・酸化防止
剤を加熱溶解したものを添加して混合し、パウダーを得
た。After mixing the four components of sericite and the color pigment from the p-methoxycinnamic acid-aminopropyltriethoxysilane-silica gel compound among the above components, methyl polysiloxane, squalane and tri-2-ethyl were mixed with stirring. A solution obtained by heating and dissolving glyceryl hexanoate and a preservative / antioxidant was added and mixed to obtain a powder.
【0049】[0049]
【発明の効果】本発明によれば、無機粉体の表面に紫外
線吸収性官能基を有しているため、経皮吸収性が低く、
従来の紫外線吸収剤と同様な紫外線吸収性を有する紫外
線防御剤を提供できる。特に、シリカゲルのように透明
性の無機粉体に適用することにより、透明度の高い紫外
線防御剤を提供できる。According to the present invention, since the surface of the inorganic powder has an ultraviolet absorbing functional group, its transdermal absorption is low,
It is possible to provide an ultraviolet ray protective agent having the same ultraviolet ray absorbency as a conventional ultraviolet ray absorbent. In particular, by applying to a transparent inorganic powder such as silica gel, an ultraviolet protective agent having high transparency can be provided.
【0050】また、シランカップリング剤を用いること
により、無機粉体の表面に簡単に導入することができ、
しかも、経皮吸収性が低いので、種々の紫外線吸収性官
能基を導入することができ、化粧品の特性に応じた幅広
い紫外線防御剤を提供できる。Further, by using a silane coupling agent, it can be easily introduced into the surface of the inorganic powder,
Moreover, because of its low transdermal absorbability, various UV-absorbing functional groups can be introduced, and a wide range of UV protective agents according to the characteristics of cosmetics can be provided.
【0051】このような紫外線防御剤を、化粧料に用い
ることにより、安全性に優れた数々の紫外線防御能を有
するサンスクリーン化粧料を提供できる。By using such an ultraviolet ray protective agent in cosmetics, it is possible to provide sunscreen cosmetics having excellent safety and various ultraviolet ray protective properties.
【図1】本発明の一実施例である紫外線防御剤の光透過
スペクトルである。FIG. 1 is a light transmission spectrum of an ultraviolet protective agent according to one embodiment of the present invention.
Claims (8)
を有することを特徴とする紫外線防御剤。1. An ultraviolet protective agent comprising an inorganic powder having an ultraviolet absorbing functional group on the surface.
表面処理されたシランカップリング剤を介して結合され
たことを特徴とする請求項1記載の紫外線防御剤。2. The ultraviolet protective agent according to claim 1, wherein the ultraviolet absorbing functional group is bonded via a silane coupling agent surface-treated to the inorganic powder.
ことを特徴とする請求項1又は2記載の紫外線防御剤。3. The ultraviolet protective agent according to claim 1, wherein the inorganic powder has a hydroxyl group on the surface.
を特徴とする請求項1、2又は3記載の紫外線防御剤。4. The ultraviolet protective agent according to claim 1, wherein the inorganic powder has a light transmitting property.
項1、2、3又は4記載の紫外線防御剤。5. The ultraviolet protective agent according to claim 1, wherein the inorganic powder is silica gel.
である請求項5記載の紫外線防御剤。6. The ultraviolet protective agent according to claim 5, wherein the particle size of the silica gel is 10 μm or less.
造方法であって、 無機粉体表面に、当該無機粉体と結合可能であって、紫
外線吸収性化合物と反応可能な反応性官能基を有するシ
ランカップリング剤を結合させ、その後、無機粉体に結
合した前記シランカップリング剤と紫外線吸収性化合物
を反応させることを特徴とする紫外線防御剤の製造方
法。7. The method for producing an ultraviolet ray protective agent according to claim 1, wherein the reactive functional group capable of binding to the inorganic powder and reacting with the ultraviolet absorbing compound is provided on the surface of the inorganic powder. A method for producing an ultraviolet protection agent, comprising: bonding a silane coupling agent having a group; and reacting the silane coupling agent bonded to the inorganic powder with an ultraviolet absorbing compound.
紫外線防御剤を含有する化粧料。8. A cosmetic comprising the ultraviolet protective agent according to claim 1, 2, 3, 4, 5, or 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3395898A JPH11222421A (en) | 1998-01-31 | 1998-01-31 | Ultraviolet light shielding agent and its production, and cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3395898A JPH11222421A (en) | 1998-01-31 | 1998-01-31 | Ultraviolet light shielding agent and its production, and cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH11222421A true JPH11222421A (en) | 1999-08-17 |
Family
ID=12401011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3395898A Pending JPH11222421A (en) | 1998-01-31 | 1998-01-31 | Ultraviolet light shielding agent and its production, and cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH11222421A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002363435A (en) * | 2001-06-12 | 2002-12-18 | Toda Kogyo Corp | Organic/inorganic composite pigment and coating material and resin composition each using the same |
| WO2005112871A1 (en) * | 2004-05-24 | 2005-12-01 | Shiseido Company, Ltd. | Water-dispersible powder for cosmetic preparation |
| JP2006502856A (en) * | 2002-10-18 | 2006-01-26 | プロメガ コーポレイション | Composition for separating molecules |
| JP2009143825A (en) * | 2007-12-12 | 2009-07-02 | Shiseido Co Ltd | Surface-treated powder and cosmetic containing the same |
| JP2012530711A (en) * | 2009-06-19 | 2012-12-06 | ユー.エス. コスメティックス コーポレイション | Cosmetic compositions and methods for enhanced UV protection |
| KR101410043B1 (en) * | 2012-08-28 | 2014-06-27 | 주식회사보광화학 | The sunblock through hybrid of nano particle of metal compound, process for producing thereof, and the cosmetic utilizing thereof |
| JP2014189553A (en) * | 2013-03-26 | 2014-10-06 | Kolmar Korea Co Ltd | Wet forming color cosmetic containing organic ultraviolet blocking agent deposited on hydrophobic-treated porous silica and method for preparing the same |
| JP2020531504A (en) * | 2017-08-30 | 2020-11-05 | カチョン ユニバーシティ オブ インダストリー−アカデミック コーオペレイション ファウンデイション | UV blocking composition containing cerium-aminoclay nanoparticles and method for producing the same |
| CN113677322A (en) * | 2019-04-05 | 2021-11-19 | 株式会社资生堂 | Powder cosmetic containing ultraviolet wavelength conversion substance and method for producing same |
| EP4094750A3 (en) * | 2021-04-29 | 2023-01-18 | Amorepacific Corporation | Organic-inorganic composite powder and composition including the same |
| US12440431B2 (en) | 2019-04-05 | 2025-10-14 | Shiseido Company, Ltd. | Cosmetic comprising ultraviolet wavelength conversion substance |
| US12472131B2 (en) | 2020-01-31 | 2025-11-18 | Shiseido Company, Ltd. | Inflammation-suppressing agent |
| US12551424B2 (en) | 2019-04-05 | 2026-02-17 | Shiseido Company, Ltd. | Oil-in-water type emulsification composition containing UV wavelength conversion substance |
-
1998
- 1998-01-31 JP JP3395898A patent/JPH11222421A/en active Pending
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002363435A (en) * | 2001-06-12 | 2002-12-18 | Toda Kogyo Corp | Organic/inorganic composite pigment and coating material and resin composition each using the same |
| EP1270686A2 (en) | 2001-06-12 | 2003-01-02 | Toda Kogyo Corporation | Organic and inorganic composite pigments, and paint and resin composition using the same |
| JP2006502856A (en) * | 2002-10-18 | 2006-01-26 | プロメガ コーポレイション | Composition for separating molecules |
| WO2005112871A1 (en) * | 2004-05-24 | 2005-12-01 | Shiseido Company, Ltd. | Water-dispersible powder for cosmetic preparation |
| JP2009143825A (en) * | 2007-12-12 | 2009-07-02 | Shiseido Co Ltd | Surface-treated powder and cosmetic containing the same |
| JP2012530711A (en) * | 2009-06-19 | 2012-12-06 | ユー.エス. コスメティックス コーポレイション | Cosmetic compositions and methods for enhanced UV protection |
| KR101410043B1 (en) * | 2012-08-28 | 2014-06-27 | 주식회사보광화학 | The sunblock through hybrid of nano particle of metal compound, process for producing thereof, and the cosmetic utilizing thereof |
| JP2014189553A (en) * | 2013-03-26 | 2014-10-06 | Kolmar Korea Co Ltd | Wet forming color cosmetic containing organic ultraviolet blocking agent deposited on hydrophobic-treated porous silica and method for preparing the same |
| JP2020531504A (en) * | 2017-08-30 | 2020-11-05 | カチョン ユニバーシティ オブ インダストリー−アカデミック コーオペレイション ファウンデイション | UV blocking composition containing cerium-aminoclay nanoparticles and method for producing the same |
| CN113677322A (en) * | 2019-04-05 | 2021-11-19 | 株式会社资生堂 | Powder cosmetic containing ultraviolet wavelength conversion substance and method for producing same |
| CN113677322B (en) * | 2019-04-05 | 2024-07-12 | 株式会社资生堂 | Powdered cosmetic containing ultraviolet wavelength conversion substance and method for producing the same |
| US12440431B2 (en) | 2019-04-05 | 2025-10-14 | Shiseido Company, Ltd. | Cosmetic comprising ultraviolet wavelength conversion substance |
| US12551418B2 (en) | 2019-04-05 | 2026-02-17 | Shiseido Company, Ltd. | Cosmetic containing ultraviolet wavelength converting substance and medicinal agent |
| US12551424B2 (en) | 2019-04-05 | 2026-02-17 | Shiseido Company, Ltd. | Oil-in-water type emulsification composition containing UV wavelength conversion substance |
| US12472131B2 (en) | 2020-01-31 | 2025-11-18 | Shiseido Company, Ltd. | Inflammation-suppressing agent |
| EP4094750A3 (en) * | 2021-04-29 | 2023-01-18 | Amorepacific Corporation | Organic-inorganic composite powder and composition including the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3819069B2 (en) | Cosmetics | |
| US5223250A (en) | Visibly transparent UV sunblock cosmetic compositions | |
| AU751756B2 (en) | Ultraviolet-screening zinc oxide excellent in transparency and composition containing the same | |
| JPH11222421A (en) | Ultraviolet light shielding agent and its production, and cosmetic | |
| JPWO1999025654A1 (en) | Zinc oxide with excellent transparency and ultraviolet shielding properties and composition containing the same | |
| AU1565692A (en) | Visibly transparent uv sunblock agents and methods of making same | |
| JPS5862106A (en) | Cosmetic | |
| US20140363387A1 (en) | Cosmetic compositions and methods for enhanced uv protection | |
| JPH0723294B2 (en) | Sunscreen cosmetics | |
| KR101210371B1 (en) | Manufacturing method of emulsion containing titanium dioxide and zinc oxide and cosmetic composition for protecting containing thereof | |
| JP3686166B2 (en) | Cosmetic composition and cosmetics | |
| WO1997038671A1 (en) | Silicone polymer-coated, hydrophobized metal oxides | |
| WO2007069430A1 (en) | Dispersion of fine titanium oxide particles and cosmetic preparation containing the same | |
| KR100684367B1 (en) | Cosmetic composition containing sunscreen polysilsesquioxane spherical particles | |
| AU703782B2 (en) | Silicone polymer-coated, hydrophobized metal oxides | |
| CN116211722B (en) | Sunscreen raw material and preparation method thereof and cosmetics | |
| JP2000044450A (en) | Composite powder containing ultraviolet light absorber and cosmetic containing the same formulated therein | |
| US11389386B2 (en) | Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens | |
| CN114502132A (en) | Near-infrared blocking agent and near-infrared blocking skin preparation for external use | |
| KR101238379B1 (en) | Titanium dioxide capsules containing ultraviolet absorber and the cosmetic composition containing the same | |
| JPH04198124A (en) | Cosmetic | |
| JP2007182382A (en) | Method for producing ultraviolet-screening zinc oxide excellent in transparency | |
| CN101472881B (en) | Benzylidene malonamide and salt thereof, ultraviolet ray absorbent, and agent for external application to the skin | |
| JPH09188611A (en) | Surface-coated flaky powder, its production and cosmetic formulated therewith | |
| CN117064774B (en) | A sunscreen agent with enhanced sun protection ability after contact with water and its preparation and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050114 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050906 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051107 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20051206 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060411 |